Medeor Therapeutics scores $57 mln Series B

San Mateo, California-based Medeor Therapeutics Inc, a developer of personalized cellular immunotherapies, has raised $57 million in Series B financing. RA Capital Management led the round with participation from other investors that included Sofinnova Ventures, 6 Dimensions Capital, Vivo Capital and WuXi Healthcare Ventures. In conjunction with the financing, Dr. Peter Kolchinsky, a portfolio manager and managing director at RA Capital and Dr. Anand Mehra, general partner at Sofinnova Ventures, have joined the Medeor's board of directors.

ManagersNorth AmericaUSHealthcareBriefs